Elevated liver enzymes: what ALT, AST and GGT mean and what comes next

The finding usually comes up in passing. A check-up, a routine test. And then there is an ALT with an asterisk, a little above the limit.

You feel fine. Nothing hurts. Still, the question is on the table: is this dangerous, or can I forget about it?

Many people know this pattern. Some read themselves into cirrhosis at night. Others hear that the value is only slightly elevated and never think about it again. Both fall short.

What liver enzymes measure and what they do not

Imagine the liver as a large warehouse. The cells hold tools, among them enzymes. When a cell is damaged, boxes fall onto the street. The lab counts the boxes. It does not measure how well the warehouse is working.

For me, this is the most important sentence about liver enzymes: the classic enzymes show damage, not performance. The British guideline on the investigation of abnormal liver tests frames it the same way.

The individual values

GPT and GOT, as they are still often called in German lab reports, are today named ALT and AST, the transaminases. ALT sits mainly in the liver. According to the British guideline, AST is also abundant in skeletal, heart and smooth muscle, so an elevated AST can come from muscle.

GGT is sensitive and not very specific. According to the British guideline, it is most often raised by excess weight, heavy alcohol use or medications. At the same time, the same guideline counts it among the best predictors of liver mortality.

Alkaline phosphatase (ALP) comes from the bile ducts and bone. For an isolated elevated ALP, the British guideline states there are no data on the most common cause, and the guideline group estimates vitamin D deficiency or, in children, growth. GGT is useful for telling them apart, because it does not occur in bone.

Bilirubin: if it is slightly elevated on its own, the most common explanation according to the British guideline is Gilbert syndrome. According to this guideline, it affects 5 to 8 percent of the population and is not associated with liver disease.

Abnormal values are everyday business. In Birmingham in 2016, 38,636 of 130,849 requests, or 30 percent, had at least one value outside the reference range. As a starting point, the guideline recommends bilirubin, albumin, ALT, ALP and GGT together with a full blood count.

Why there is no universally valid table of normal values

You will not find a table of normal values here. Reference ranges depend on the measurement method, the lab, sex and the comparison group. And where healthy ends is disputed among experts.

The professional societies draw different conclusions. In 2017, the American College of Gastroenterology named a truly healthy ALT range of 29 to 33 IU/l in men and 19 to 25 IU/l in women. The 2024 European MASLD guideline considers ALT above 33 U/l in men and above 25 U/l in women as elevated. The British guideline calls a value abnormal if it lies outside the lab range. These are guideline quotations, not a yardstick for comparing yourself. As with ferritin, a value only gains meaning in context.

And now you know why a liver value means little without context.

The most common cause: fatty liver with metabolic dysfunction

You hardly drink alcohol. And yet the ultrasound report says hepatic steatosis, and the doctor's letter has a new abbreviation: MASLD. Many people feel caught out at this moment. But the finding says nothing about discipline. It says something about metabolism.

The inflammatory form is now called MASH. The German Society for Gastroenterology, Digestive and Metabolic Diseases, DGVS for short, adopted the new names into its guideline by amendment in 2024.

For Germany, the 2022 DGVS guideline cites about 23 percent in 2016, from a mathematical modelling study that expects about 26 percent for 2030. With risk factors, the prevalence rises to 60 to 75 percent according to the guideline. A team led by Bashir compared two surveys of the Study of Health in Pomerania. Between 1997 to 2001 and 2008 to 2012, hepatic steatosis there rose from 29.7 to 37.3 percent, most markedly in women and younger people.

The DGVS writes that fatty liver generally causes no symptoms and is often discovered by chance. It becomes important in two ways: through scarring, which is considered the most important factor for the further course of the liver, and through the heart. According to the 2024 European guideline, people with MASLD have a higher risk of non-fatal cardiovascular events, hazard ratio 1.40. And fatty liver also occurs at normal weight; the DGVS devotes separate statements to this group.

How fructose is processed in the liver is covered in Sugar and fructose: the liver is where it happens. How insulin resistance connects weight and the liver, in Insulin resistance and weight loss.

And now you know why, with an elevated ALT, the first question almost always concerns metabolism.

Alcohol, medications and dietary supplements

The question about alcohol is uncomfortable, for both sides. And many people answer the question about medications with a quick no. Yet what is often missing from the list is exactly what nobody considers a medication: the painkiller from the weekend, the turmeric shot, the powder from the gym.

Alcohol

The 2022 DGVS guideline states that the amount of alcohol at which the liver is damaged varies from person to person. To distinguish fatty liver from alcohol-related liver disease, it uses 10 g per day for women and 20 g for men. That is a diagnostic cut-off, not a safe amount. As indirect indicators, the European guideline names GGT, AST, an AST higher than ALT, the volume of red blood cells and CDT. None of these values proves anything on its own.

A decline is still measurable early on: in a cohort led by Pol with 416 people, GGT in people with an alcohol problem already fell in the first week in hospital. Important for safety: anyone who has drunk heavily and regularly for a long time should not stop abruptly on their own. Withdrawal can become physically dangerous and needs medical supervision. Your family doctor and addiction counselling services are good first points of contact. What alcohol changes in the gut is described in Alcohol and the gut.

Paracetamol, antibiotics and statins

Statins appear on many lists of drugs that can raise liver enzymes. However, the concern that people with already elevated values are at particular risk was not confirmed in a large analysis led by Chalasani. Among 342 people with elevated baseline values who started a statin, mild to moderate elevations occurred in 4.7 percent and severe ones in 0.6 percent. Among 2,245 people with elevated values without a statin, the figures were 6.4 and 0.4 percent, so there was no significant difference.

So let me say it explicitly: if you take a statin and your liver enzymes are elevated, do not stop it on your own. Whether the statin plays a role and what follows from that is something you clarify with the doctor who prescribed it. Whether a statin is indicated at all is something I discuss in Statins from age 35?

This does not make dietary supplements bad in principle, as I describe in Dietary supplements: when they make sense. With elevated liver enzymes, however, every product belongs on the table. The British and American guidelines call for asking about all remedies, including over-the-counter ones.

And now you know why the question about alcohol, medications and supplements comes first, and why it should be asked without reproach.

When it is not just the liver: exercise, stress and rarer causes

Sunday, heavy squats for the first time. Tuesday, a blood test. Thursday, the call: AST and ALT elevated, please recheck. This sequence is not rare, and it shows that a liver value does not always tell a story about the liver.

Creatine kinase, a muscle enzyme, is helpful here. If it is elevated as well and GGT and ALP remain unremarkable, muscle moves to the front as the source. That is a pointer for the medical assessment, not a self-diagnosis, and not a reason against strength training.

Stress: what is established and what is not

Whether stress raises liver enzymes is a very common question. In the studies reviewed for this article, nobody measured this directly. What is established are associations. A team led by Kang found slightly more frequent fatty liver among 171,321 apparently healthy adults in the top fifth of perceived stress, odds ratio 1.17, in a snapshot that says nothing about cause and effect. A team led by Russ saw in 16 cohorts with 166,631 people that severe psychological distress was associated with higher mortality from liver disease, but liver values were not measured.

Plausible, not proven, are indirect routes via sleep, eating, alcohol and physical activity. If you are carrying a lot right now, this is not a question of blame. It is a reason to take the stress itself seriously.

Viral hepatitis and rarer causes

Hepatitis B and C are part of the British basic panel and can run without symptoms for a long time. In Germany, following a decision by the Federal Joint Committee, insured people aged 35 and over have been entitled to a one-time test for hepatitis B and C since 1 October 2021, as part of the check-up in statutory health insurance.

Haemochromatosis. In this hereditary iron storage disease, according to the 2022 European guideline, transferrin saturation is elevated and iron is deposited mainly in the liver. Early diagnosis and phlebotomy can prevent cirrhosis, liver cancer, diabetes and joint damage. The thresholds named there apply to diagnosis in a specific gene variant, not as general normal values for ferritin. An elevated ferritin alone is not yet iron overload, because it also rises with inflammation and fatty liver. More in Ferritin: what is normal and Iron overload: how dangerous is it.

Wilson disease is a hereditary disorder of copper metabolism. The 2025 European guideline bases the diagnosis on, among other things, ceruloplasmin, copper in 24-hour urine and genetic analysis, and recommends the Leipzig score. The British guideline includes ceruloplasmin in the extended panel for ages 3 to 40.

Autoimmune hepatitis, according to the 2025 European guideline, can occur at any age, ranging from no symptoms to acute liver failure. Autoantibodies and immunoglobulins are already part of the British standard panel.

Coeliac disease. A team led by Aggarwal pooled 20 studies with 4,265 people. At diagnosis of coeliac disease, a pooled 18.7 percent had elevated liver enzymes, with very heterogeneous individual studies. On a gluten-free diet, 83.1 percent were back in the normal range. Among 979 people with unexplained elevated values, biopsy-confirmed coeliac disease was found in 4.5 percent. Important: test first, then change your diet. More in Recognizing coeliac disease.

Thyroid. In a meta-analysis led by Mantovani, hypothyroidism occurred more often together with fatty liver, odds ratio 1.42 in the cross-sectional data, but in longitudinal data subclinical hypothyroidism was not independently associated with new fatty liver. Cause and effect remain open. Thyroid values are part of the British extended panel, and thyroid medication is not changed on your own because of a liver value. More in Thyroid blood tests: which ones really count.

And now you know why an elevated value after hard training is read differently from the same value without a trigger.

Reading the pattern: hepatocellular, cholestatic and the De Ritis ratio

Two reports, both noting elevated liver enzymes. In one, ALT is far up and ALP is unremarkable. In the other, it is the other way around. For the next question, these are two different worlds.

Imagine the liver as a factory with a drainage channel. The liver cells are the workshops, the bile ducts the channel. If there is a fire in the workshops, ALT and AST rise above all. If the channel backs up, ALP and GGT rise above all.

These definitions come from the 2017 guideline of the American College of Gastroenterology. The US database LiverTox translates the pattern into the R value: ALT and ALP are each expressed as a multiple of their upper limit and divided by each other. From 5 the pattern counts as hepatocellular, up to 2 as cholestatic, and in between as mixed. LiverTox also describes that drug-induced liver injury most often occurs without jaundice and usually without symptoms. The calculation is simple, yet the interpretation still belongs in medical hands, because the time course, medications and earlier results are read alongside it.

GGT elevated, AST and ALT normal: according to the British guideline, the most common reasons are excess weight, heavy alcohol use or medications, and bile flow comes into play as well. If ALP rises too, the bile moves more into focus, more on this in Gallbladder, bile and the gut. Because GGT in the cohorts was associated with more than the liver, it is also worth looking at blood sugar, blood lipids and blood pressure.

The De Ritis ratio: AST divided by ALT

In a review, Botros and Sikaris explain why the ratio fluctuates: AST has a half-life of about 18 hours, ALT of about 36. So the ratio also reflects the time course. In chronic viral hepatitis, long-term alcohol use and fatty liver, an elevated ratio predicted scarring and cirrhosis. The British guideline puts it briefly: a ratio above 1 points to advanced fibrosis or cirrhosis, and AST and ALT may be normal even in cirrhosis. However, a diagnostic study led by McPherson found that the ratio detected advanced fibrosis less well than the FIB-4 score in all age groups.

And now you know why two reports with the same sentence can lead in completely different directions.

What comes next: the stepwise pathway of the guidelines

After an abnormal result, the pressing question is rarely what the value means. It is: and now what? The guidelines answer this surprisingly clearly.

The 2018 British guideline contains four statements that I consider the most important on this topic. Liver tests should only be interpreted after reviewing earlier results, the medical history and the current condition. The degree of elevation is not necessarily a measure of its significance. The search for a cause should be considered regardless of level and duration. And the standard panel for adults includes ultrasound, tests for hepatitis B and C, autoantibodies, immunoglobulins, ferritin and transferrin saturation. The 2017 American guideline sets a different emphasis: there, the degree of elevation serves to steer the workup.

The 2022 DGVS guideline does not recommend screening the general population for fatty liver. With risk factors, however, a non-invasive assessment should be carried out, and elevated liver enzymes alone are not sufficient as a decision criterion. The 2024 European guideline names three groups for the search for scarring: people with type 2 diabetes, people with increased abdominal fat and at least one other metabolic risk, and people with persistently elevated liver enzymes. Both rely on two steps, because scores and elastography detect fibrosis more accurately than the usual liver tests.

The DGVS writes that with the low cut-off of 1.3, advanced fibrosis can be ruled out with high probability because of the negative predictive value of at least 90 percent. For values between 1.3 and 2.67 and from 2.67, elastography follows. The European guideline adds: below 1.3 the risk is low and reassessment every one to three years is possible, yet the score still misses about 10 percent of advanced fibrosis cases. Above the age of 65, the threshold is 2.0, as the 2025 DGVS amendment also states. Between 1.3 and 2.67, instead of elastography, one year of intensified lifestyle change and treatment of cardiometabolic risk factors followed by a repeat FIB-4 is also possible.

Elastography uses ultrasound, without a needle, to measure how stiff the liver is; a well-known example is FibroScan. The 2022 DGVS guideline names values below 8 kPa and above 12 kPa as the limits for ruling out or diagnosing advanced fibrosis, and values in between need further assessment. Its amendment of November 2025, written with a view to possible drug treatment, is more fine-grained: at 10 to 19.9 kPa, significant fibrosis of stages F2 to F3 should be assumed, and at 8 to 10 kPa the measurement should be repeated after six months, both as a recommendation.

And now you know why an elevated liver value is followed neither by panic nor by a shrug, but by a pathway with clear steps.

Normal liver enzymes, and still fatty liver or fibrosis

Your liver enzymes have always been normal. And then the ultrasound shows steatosis. How does that fit together? Quite well, unfortunately.

Scarring also hides behind normal values. A team led by Mofrad examined biopsies from 51 people with fatty liver and normal ALT. 12 had bridging fibrosis, 6 had cirrhosis. The spectrum did not differ substantially from that of people with elevated ALT. The group was selected, for example through assessment as living donors, so no frequency can be derived from it. A meta-analysis of 11 studies led by Ma found a normal ALT in 25 percent of people with fatty liver in clinical populations. That this share is lower than in Browning's study could be related to the fact that clinics tend to see people with abnormal values.

The guidelines draw the same conclusion. The DGVS writes that elevated liver enzymes alone are not sufficient as a decision criterion, because fatty liver can be present even with normal transaminases. The European guideline adds that people with MASLD and normal values can develop relevant inflammation and advanced fibrosis. The British guideline states that AST and ALT may be normal even in cirrhosis.

And now you know why the guidelines look for scarring in people with risk factors even when the lab report is unremarkable.

What improved the values and the liver in studies

After every finding comes the question: what can I do? The answer starts with the cause. If a prescribed medication is under suspicion, you clarify this with the doctor who prescribed it. A virus or an iron storage disease needs its own treatment. For the most common cause, metabolic fatty liver, there are good studies.

Weight: a dose-response relationship, without a moral undertone

The 2022 DGVS guideline names similar orders of magnitude for people with excess weight: at least 5 percent weight reduction for steatosis, inflammation and transaminases, as a strong recommendation, and at least 10 percent for fibrosis, as a recommendation. The European guideline grades 5 percent for liver fat, 7 to 10 percent for inflammation and 10 percent for fibrosis, as a strong recommendation. For people of normal weight, the DGVS describes a controlled study in which steatosis regressed in 50 percent with 3 to 5 percent weight reduction. These are study and guideline figures, not personal targets. Diets and strong restriction carry their own risks, especially after many attempts at dieting, more on this in Understanding eating disorders.

In 2022, the DGVS stated that at that time no medication was approved specifically for this indication. In November 2025, it added an amendment on resmetirom to its guideline, which is now called Metabolic Liver Diseases. According to this amendment, the drug holds a conditional European marketing authorisation for adults with MASH without cirrhosis and with moderate to advanced fibrosis, in combination with diet and exercise. Which drug option may be suitable for whom belongs in a hepatology consultation.

Alcohol, physical activity and diet quality

The DGVS recommends that people with fatty liver reduce moderate alcohol consumption, and that people with cirrhosis avoid alcohol and nicotine entirely. For advanced fibrosis or cirrhosis, the European guideline calls for stopping alcohol completely and permanently. Anyone who has drunk heavily and regularly for a long time should take this step with medical supervision too, as described in the section on alcohol.

With physical activity, a closer look is worthwhile. A meta-analysis of 12 studies led by Keating found that exercise lowered liver fat, even with little or no weight loss. Exercise alone, however, had no significant effect on ALT. So liver fat can fall before the lab value shows it. The DGVS recommends three hours of aerobic training per week at moderate to medium intensity, quoted here as a guideline statement. What physical activity can change at the cellular level is covered in Exercise as medicine, and why even sitting less counts, in Sitting as a health risk.

For food, the European guideline describes a Mediterranean-style diet with plenty of vegetables, legumes, olive oil and nuts, with few highly processed foods and without sugar-sweetened beverages. Why unprocessed food satisfies differently is described in Unprocessed food.

Coffee and milk thistle: two honest assessments

Coffee. A team led by Xiao analyzed the US survey NHANES with 27,793 adults. Those who drank at least three cups a day had abnormal liver enzymes less often than people who drank no coffee. The odds ratios were 0.75 for ALT, 0.82 for AST, 0.73 for ALP and 0.69 for GGT. Decaffeinated coffee showed a similar association for ALT. A meta-analysis of nine observational studies with 432,133 participants led by Kennedy found a relative risk of cirrhosis of 0.56 per two additional cups a day. These are associations, not proof. The DGVS says coffee could be recommended to people with fatty liver, as an open recommendation. If you react to caffeine with restlessness, palpitations or poor sleep, you will find an assessment in Coffee, cortisol and adenosine.

Milk thistle. A Cochrane team led by Rambaldi pooled 18 randomized trials with 1,088 people with alcohol-related or viral liver disease: no significant effect on mortality, complications or tissue, with predominantly low study quality. In a randomized trial led by Wah Kheong with 99 people with steatohepatitis, silymarin missed the primary endpoint, with 32.7 percent versus 26.0 percent on placebo. In a secondary endpoint, fibrosis decreased in 22.4 versus 6.0 percent, which still needs to be confirmed. A meta-analysis of eight studies led by Kalopitas found transaminases falling more than with placebo, with quality limitations. Based on the evidence, the DGVS advises with a strong recommendation against the general use of silymarin in fatty liver. The European guideline writes that silymarin may improve liver enzymes, but that an improvement in tissue has not been documented in the few small studies. The in-depth look is in Milk thistle and the liver.

And the liver cleanse? What detoxification means and what part of it is marketing is covered in Liver detox: what counts, and the biochemistry behind it in Phase 1 and phase 2 of liver detoxification.

If you only do three things today: gather your earlier reports and a complete list of all medications and supplements. Talk openly about alcohol and training before the blood test. And ask about the pattern of your values and, if you have metabolic risks, about FIB-4. If you would like to work through the assessment together, you will find the option to book an appointment below this article.

And now you know why an elevated liver value is not a verdict, but the start of a question that can be answered well.

Frequently asked questions about elevated liver enzymes

Where the liver connects to other topics

The liver is linked to blood sugar, bile, the gut, iron, the thyroid and muscles. These articles lead on from here.